Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
L AreccoM BruzzoneR BasH J KimA Di MeglioR Bernstein-MolhoF S HilbersK PogodaE CarrascoK PunieJ BajpaiE AgostinettoN Lopetegui-LiaA H PartridgeK A PhillipsA TossC Rousset-JablonskiG CuriglianoT RenaudA FerrariS Paluch-ShimonR FruscioW CuiS M WongC VernieriF J CouchM V DieciA MatikasM RozenblitD Aguilar-Y MéndezL De MarchisF PuglisiA FabiS L GraffI WitzelA Rodriguez HernandezA FontanaR PesceR DuchnowskaH L PaisV SiniE SokolovićE de AzambujaM CeppiE BlondeauxM LambertiniPublished in: Annals of oncology : official journal of the European Society for Medical Oncology (2024)
In young BRCA carriers, differences in recurrence pattern and second primary breast cancer among hormone receptor-positive versus negative disease warrant consideration in counseling patients on treatment, follow-up, and risk-reducing surgery.
Keyphrases
- end stage renal disease
- breast cancer risk
- ejection fraction
- minimally invasive
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- smoking cessation
- patient reported outcomes
- acute coronary syndrome
- atrial fibrillation
- young adults
- hiv infected
- antiretroviral therapy
- replacement therapy